FDA.reportPublic FDA data

Carbaglu 200 MG Tablet for Oral Suspension

RxCUI
905394
RxNorm name
Carbaglu 200 MG Tablet for Oral Suspension
Display name
Carbaglu 200 MG Tablet for Oral Suspension
Full name
Carbaglu 200 MG Tablet for Oral Suspension
Term type
PSN
Status
DailyMed mapping
Updated
2026-06-04 23:38:47

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
CarbagluCARGLUMIC ACIDRecordati Rare Diseases10175e73-5172-4dde-a508-8a88b7afc0a12024-01-25Adverse reactionsExact identifier
rxcui: 905394

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 1 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
10175e73-5172-4dde-a508-8a88b7afc0a1Carbaglu 200 MG Tablet for Oral Suspension [PSN] · carglumic acid 200 MG Tablet for Oral Suspension [Carbaglu] [SBD] · Carbaglu 200 MG Dispersible Tablet for Oral Suspension [SY]336These highlights do not include all the information needed to use CARBAGLU safely and effectively. See full prescribing information for CARBAGLU. Carbaglu ® (carglumic acid) tablets for oral suspension Initial U.S. Approval: 201020240125